Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Faculty Members have conducted research related to the Bioactive Foods and Medicinal Plants for Cardiovascular Complications of Type Ii Diabetes: Current Clinical Evidence and Future Perspectives
Mehdi Mehrani
Mehdi Mehrani

Assistant Professor of Cardiology

Department Cardiology

School of Medicine

Tehran Heart Center

Tehran Heart Research Center

Tehran University of Medical Sciences

All Documents
1. Predicting In-Hospital Mortality in Patients With Acute Myocardial Infarction: A Comparison of Machine Learning Approaches, Clinical Cardiology (2025)
2. Time Trends in Major Adverse Cardiovascular Events After Percutaneous Coronary Intervention: Meta-Analysis on Sex Differences, JACC: Advances (2025)
3. Comparative Analysis of Pci Strategies in Aortic Stenosis Patients Undergoing Tavi: A Systematic Review and Network Meta-Analysis, Clinical Cardiology (2024)
4. Comparison of Machine-Learning Models for the Prediction of 1-Year Adverse Outcomes of Patients Undergoing Primary Percutaneous Coronary Intervention for Acute St-Elevation Myocardial Infarction, Clinical Cardiology (2024)
5. Impact of Multiarterial Revascularization on Long-Term Major Adverse Cardiovascular Events After Coronary Bypass in 23,798 Patients, Annals of Thoracic Surgery (2024)
6. Machine Learning Prediction of One-Year Mortality After Percutaneous Coronary Intervention in Acute Coronary Syndrome Patients, International Journal of Cardiology (2024)
7. Prediabetes and Major Adverse Cardiac Events After Acute Coronary Syndrome: An Overestimated Concept, Clinical Cardiology (2024)
8. Predictive Modeling for Acute Kidney Injury After Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrome: A Machine Learning Approach, European Journal of Medical Research (2024)
9. Risk Factor Profile and Outcomes of Premature Acute Coronary Syndrome After Percutaneous Coronary Intervention: A 1-Year Prospective Design, Clinical Cardiology (2024)
10. Risk Factor Profile and Outcomes of Premature Acute Coronary Syndrome After Percutaneous Coronary Intervention: A 1-Year Prospective Design, Clinical Cardiology (2024)
11. Sex-Based Association Between High-Density Lipoprotein Cholesterol and Adverse Outcomes After Coronary Artery Bypass Grafting, BMC Cardiovascular Disorders (2024)
12. The Association Between Metabolic Syndrome and Major Adverse Cardiac and Cerebrovascular Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention, Scientific Reports (2024)
13. Trends in Transcatheter Versus Surgical Aortic Valve Replacement Outcomes in Patients With Low-Surgical Risk: A Systematic Review and Meta-Analysis of Randomized Trials, Journal of the American Heart Association (2024)
14. Triglyceride-Glucose Index As a Predictor of Cardiac Adverse Events in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention: Role of Diabetes, BMC Cardiovascular Disorders (2024)
15. In-Hospital and 1-Year Outcomes of Patients Without Modifiable Risk Factors Presenting With Acute Coronary Syndrome Undergoing Pci: A Sex-Stratified Analysis, Frontiers in Cardiovascular Medicine (2023)
16. In-Hospital and 1-Year Outcomes of Patients Without Modifiable Risk Factors Presenting With Acute Coronary Syndrome Undergoing Pci: A Sex-Stratified Analysis, Frontiers in Cardiovascular Medicine (2023)
17. Cost-Effectiveness of Sacubitril/Valsartan Compared With Enalapril in Patients With Heart Failure With Reduced Ejection Fraction: A Systematic Review, Journal of Tehran University Heart Center (2022)
18. Evaluation of the Practice Guideline Used for Rule-Out of Myocardial Infarction at a Tertiary Cardiology Center, Critical Pathways in Cardiology (2022)
19. Prognostic Significance of Positive Family History in Outcomes After Coronary Artery Bypass Grafting: Do We Need to Update Our Assumptions?, Journal of Cardiothoracic Surgery (2022)
20. Prevalence and Trends of Coronary Artery Disease Risk Factors and Their Effect on Age of Diagnosis in Patients With Established Coronary Artery Disease: Tehran Heart Center (2005–2015), BMC Cardiovascular Disorders (2021)
21. Device-Based Treatment of Heart Failure, Nanomedicine for Ischemic Cardiomyopathy: Progress# Opportunities# and Challenges (2020)
22. Ischemic Cardiomyopathy, Nanomedicine for Ischemic Cardiomyopathy: Progress# Opportunities# and Challenges (2020)
23. Pulmonary Thromboembolism As a Potential Cause of Clinical Deterioration in Covid-19 Patients; a Commentary, Archives of Academic Emergency Medicine (2020)
24. The Need for Permanent Pacemaker After Restoration of Conduction Following Atrioventricular Block: A Retrospective Cohort Study; [Atriyoventrikuler Blogu Takiben Iletimin Restorasyonu Sonrasi Kalici Kalp Pili Gereksinmesi: Geriye Donuk Bir Kohort Calismasi], Turk Kardiyoloji Dernegi Arsivi (2020)
25. Nanoscale Technologies for Prevention and Treatment of Heart Failure: Challenges and Opportunities, Chemical Reviews (2019)
26. Coronary Artery Dissection in a 33-Year-Old Man With Fatigue and Episodic Retrosternal Burning: A Case Report, European Heart Journal - Case Reports (2018)
27. Focal Myopericarditis As a Rare But Important Differential Diagnosis of Myocardial Infarction; a Case Series, Emergency (2016)
28. Treatment Outcomes of Compartment Syndrome in Bam Earthquake Victims, Iranian Journal of Epidemiology (2010)